Literature DB >> 3593262

The effects of chemically modifying serum apolipoproteins on their ability to activate lipoprotein lipase.

P F Dodds, A Lopez-Johnston, V A Welch, M I Gurr.   

Abstract

Lipoprotein lipase activity was measured in an acetone-dried-powder preparation from rat epididymal adipose tissue using pig serum or pig serum lipoprotein, which had been chemically modified, as activator. Modification of acidic amino acids of lipoproteins with NN-dimethyl-1,3-diamine resulted in a complete loss of ability to activate lipoprotein lipase. Modification of 34% of lipoprotein arginine groups with cyclohexanedione resulted in the loss of 75% of the activation of lipoprotein lipase; approx. 42% of the original activity was recovered after reversal of the modification. This effect was dependent on the cyclohexanedione concentration. Modification of 48% of lipoprotein lysine groups with malonaldehyde decreased the maximum activation by 20%, but three times as much lipoprotein was required to achieve this. Non-enzymic glycosylation of lipoprotein with glucose, under a variety of conditions resulting in up to 28 nmol of glucose/mg of protein, had no effect upon the ability to activate lipoprotein lipase. In contrast non-enzymic sialylation resulted in a time-dependent loss of up to 60% of ability to activate lipoprotein lipase. Reductive methylation and acetoacetylation of serum did not affect the ability to activate lipoprotein lipase. The results are compared to the effects of similar modifications to low density lipoproteins on receptor-mediated endocytosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3593262      PMCID: PMC1147729          DOI: 10.1042/bj2420471

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins.

Authors:  R W Mahley; T L Innerarity; R E Pitas; K H Weisgraber; J H Brown; E Gross
Journal:  J Biol Chem       Date:  1977-10-25       Impact factor: 5.157

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.

Authors:  S K Basu; J L Goldstein; G W Anderson; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

4.  A stable, radioactive substrate emulsion for assay of lipoprotein lipase.

Authors:  P Nilsson-Ehle; M C Schotz
Journal:  J Lipid Res       Date:  1976-09       Impact factor: 5.922

5.  Mechanisms of heat damage in proteins. 4. The reactive lysine content of heat-damaged material as measured in different ways.

Authors:  R F Hurrell; K J Carpenter
Journal:  Br J Nutr       Date:  1974-11       Impact factor: 3.718

6.  Studies on the fractionation of mucosal homogenates from the small intestine.

Authors:  G Hübscher; G R West; D N Brindley
Journal:  Biochem J       Date:  1965-12       Impact factor: 3.857

7.  Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein.

Authors:  W V Brown; M L Baginsky
Journal:  Biochem Biophys Res Commun       Date:  1972-01-31       Impact factor: 3.575

8.  Plasma triglyceride transport kinetics in diabetes mellitus.

Authors:  E A Nikkilä; M Kekki
Journal:  Metabolism       Date:  1973-01       Impact factor: 8.694

9.  Primary structure of very low density apolipoprotein C-II of human plasma.

Authors:  R L Jackson; H N Baker; E B Gilliam; A M Gotto
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

10.  Simple liquid-liquid partition system for isolation of labeled oleic acid from mixtures with glycerides.

Authors:  P Belfrage; M Vaughan
Journal:  J Lipid Res       Date:  1969-05       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.